PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

Cancer Peptide Market Opportunity To Surpass US$ 18 Billion By 2030 Says Kuick ResearchDelhi, Nov. 25, 2024 (GLOBE NEWSWIRE) ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

VMT-alpha-NET is a somatostatin receptor type 2-targeted radiopharmaceutical therapy that can be radiolabeled with either 203Pb for patient selection and dosimetry assessments, or 212Pb for ...

Plant-based pigment with antioxidant and anticancer properties breaks down easily in the gastrointestinal tract and under ...

The large-scale production of recombinant proteins in plants is limited by relatively low yields and difficulties in extraction and purification. These problems were addressed by engineering ...

Medscape Medical News, November 20, 2024 ImmunoPET Tracer Can Detect Common Kidney Cancers PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert ...

Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

It provides services to 29 countries, working hand-in-hand with more than 31 pharmaceutical companies to develop and produce life-saving nuclear medicines, including those radiolabeled with 186 Re.